Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Prenetics Global Limited (NASDAQ: PRE) (Prenetics or the Company), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the third quarter ended September 30,…